NAVIDEA BIOPHARMACEUTICALS I's ticker is NAVB and the CUSIP is 63937X202. A total of 30 filers reported holding NAVIDEA BIOPHARMACEUTICALS I in Q1 2020. The put-call ratio across all filers is 0.79 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $48,000 | -5.9% | 28,465 | 0.0% | 0.00% | – |
| Q2 2021 | $51,000 | +54.5% | 28,465 | +84.1% | 0.00% | – |
| Q1 2021 | $33,000 | -58.2% | 15,465 | -57.1% | 0.00% | – |
| Q4 2020 | $79,000 | -6.0% | 36,065 | +14.1% | 0.00% | – |
| Q3 2020 | $84,000 | -22.9% | 31,615 | +14.8% | 0.00% | -100.0% |
| Q2 2020 | $109,000 | +738.5% | 27,540 | +82.5% | 0.00% | – |
| Q1 2020 | $13,000 | -27.8% | 15,090 | 0.0% | 0.00% | – |
| Q4 2019 | $18,000 | +63.6% | 15,090 | +15.3% | 0.00% | – |
| Q3 2019 | $11,000 | +120.0% | 13,090 | -0.4% | 0.00% | – |
| Q2 2019 | $5,000 | – | 13,142 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| FNY Investment Advisers, LLC | 199,220 | $151,000 | 0.12% |
| Allred Capital Management, LLC | 20,528 | $15,000 | 0.01% |
| PATHSTONE FAMILY OFFICE, LLC | 10,050 | $8,000 | 0.00% |
| LifePlan Financial Group, Inc | 1,440 | $1,000 | 0.00% |
| VICTORY CAPITAL MANAGEMENT INC | 4,806 | $4,000 | 0.00% |
| UBS Group AG | 105 | $0 | 0.00% |
| Sowell Financial Services LLC | 2,819 | $2,000 | 0.00% |
| IFP Advisors, Inc | 50 | $0 | 0.00% |
| OSAIC HOLDINGS, INC. | 6 | $0 | 0.00% |
| Jacobi Capital Management LLC | 1,000 | $1,000 | 0.00% |